Navigation Links
Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
Date:1/8/2009

Kidney transplantation to be Quark's second indication with clinical-stage, systemically administered siRNA product candidate

FREMONT, Calif., Jan. 8 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that it has initiated patient dosing in its Phase I/II clinical trial evaluating its systemically administered siRNA drug candidate QPI-1002 (previously referred to as DGFi) for prevention of Delayed Graft Function (DGF) in patients undergoing deceased donor kidney transplantation. DGF represents Quark's second indication being evaluated for the systemically administered dug candidate in human clinical trials. This trial follows two currently enrolling Phase I clinical trials in acute kidney injury (AKI).

The multi-center, two-part Phase I/II clinical trial in DGF is expected to enroll up to 204 adult kidney transplant recipients. The first part of the study is a dose-escalation design to evaluate the safety and tolerability of a single intravenous injection of QPI-1002 in renal transplant patients at high risk to develop DGF. The second part of the study will evaluate safety and potential clinical activity of a selected dose of QPI-1002 in the same patient population. Patients will be enrolled in clinical sites in the United States.

Shai Erlich, Ph.D., Chief Medical Officer of Quark, commented, "The initiation of patient dosing with QPI-1002 is an important milestone for Quark as well as being an innovative approach to offer therapeutic benefit to adult kidney transplant patients at high risk for developing DGF. The siRNA drug candidate is based on the proprietary concept of Quark and reflects Quark's success in developing products originating from conceptually novel internal developments. These accomplishments further validate Quark's ability to advance innovative product candida
'/>"/>

SOURCE Quark Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
2. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
3. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
4. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
5. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
6. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
7. Quark Pharmaceuticals Appoints New Chief Medical Officer
8. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
9. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... /PRNewswire-iReach/ -- SAM Medical Products Implements Voluntary Recall ... Junctional Tourniquet.  Photo - ... announced today that it has begun notifying customers ... issue with a clip used to secure the ... the SAM Junctional Tourniquet (SJT).  The company discovered ...
(Date:8/29/2014)... , Aug. 29, 2014  A Boston Scientific ... study on stent removability and preliminary long term ... published in the August issue of the peer-reviewed ... 1 is being conducted in 11 countries ... covered self-expanding metal stents (FCSEMS) after extended indwell ...
(Date:8/29/2014)... 29, 2014 Medina Medical announced today that ... of the Board of Directors on August 18, 2014. ... and commercialization experience, including over a decade of direct ... as a Partner of the medical device incubator The ... two Foundry start-ups. Mr. Engelson previously served as the ...
Breaking Medicine Technology:SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2
... 1 October is American Pharmacists Month and ... provide outstanding care to their patients every day ... specialty pharmacies across the country. (Logo: ... Pharmacists Month is a time to recognize the ...
... national initiative, the Pediatric Trials Network (PTN), was created ... the National Institutes of Health (NIH).  The PTN will ... Shriver National Institute of Child Health and Human ... medical centers, including Children,s Mercy Hospitals and Clinics.   ...
Cached Medicine Technology:CVS Caremark Recognizes Its 26,000 Pharmacists During October's American Pharmacists Month 2New National Program to Study and Establish Pediatric Dosing 2New National Program to Study and Establish Pediatric Dosing 3
(Date:8/30/2014)... Atlanta based automotive group Jim Ellis ... money and awareness for ALS by participating in the ... and even Vice President Jimmy Ellis all participated in ... be viewed on their Youtube page; https://www.youtube.com/watch?v=pxufyxVo9j0 . ... managers and staff also took the opportunity to challenge ...
(Date:8/30/2014)... Fast hosting is a great choice for webmasters ... professional web hosting suppliers and announces that Bluehost, ... suppliers of fastest web hosting in 2014. , ... hosting supplier. Actually, these companies have outperformed their ... customer support. People can get the best web ...
(Date:8/30/2014)... 2014 United Theological Seminary is pleased to ... the Master of Theological Studies (MTS). , ... designed for students who wish to pursue further academic study ... to serve the Church and community. Previously, students needed to ... can attend classes from any location where there is an ...
(Date:8/30/2014)... Daily Gossip reveals in its recently published review that the ... Sarah Summer, who can perfectly understand what suffering from yeast ... actually had to deal with this disorder, too. Her method ... it, in an all-natural holistic cure program. , So, Sarah ... for yeast infection. The author of this program suffered from ...
(Date:8/30/2014)... Hicksville, NY (PRWEB) August 30, 2014 ... Organizations throughout the planet has been one of ... in order to create a positive impact around ... aesthetics and staffed with top trained executives and ... millions of people worldwide. Vital statistics demonstrate ...
Breaking Medicine News(10 mins):Health News:Jim Ellis Automotive Group Take the ALS Ice Bucket Challenge 2Health News:Fastest Web Hosting Suppliers In 2014 Announced By Top10BestSEOHosting.com 2Health News:United Theological Seminary Announces First Fully Online Degree 2Health News:Natural Cure for Yeast Infection Review Exposes New Natural Treatment 2Health News:Cradle of Aviation Museum Opens Its Doors to Long Island Scientologists 2
... People suffering from fatty liver disease may be three times ... liver, according to a study by researchers at St. Michael,s ... the first to find a link between nonalcoholic fatty liver ... in the liver in non drinkers and stroke. ...
... Mass.Consumers may place a high value on information to predict ... of pocket to get it. In a national survey conducted ... indicated that they would take a hypothetical predictive test to ... or prostate cancer, or arthritis. On average, respondents were willing ...
... THURSDAY, Jan. 6 (HealthDay News) -- A blood test that ... may one day be used to detect Alzheimer,s and other ... in its infancy, being able to detect Alzheimer,s via antibodies ... the disease, researchers said. But the study,s lead author ...
... scientists holds promise for the future development of treatments ... potentially for Alzheimer,s disease and other memory-impairment diseases. ... psychology Michael Fanselow, have discovered what may be a ... disorders. The research is published Jan. 7 in the ...
... the University of Granada (UGR) warns of the need to ... autonomous communities to improve recycling and waste disposal. There is ... the Spanish Ministry of the Environment and Rural and Marine ... out a comparison of the clinical waste management regulations and ...
... and K.U.Leuven have succeeded in decoding a potential ... abnormal tumor blood vessels through HRG (histidine-rich glycoprotein) ... efficiency. In tumors, vessels formation is disturbed, leading ... cancer cells to escape to other parts of ...
Cached Medicine News:Health News:Most consumers want predictive tests to learn if a disease is in their future 2Health News:Most consumers want predictive tests to learn if a disease is in their future 3Health News:Early Steps Toward an Alzheimer's Blood Test 2Health News:Early Steps Toward an Alzheimer's Blood Test 3Health News:'Long-shot' discovery may lead to advances in treating anxiety, memory disorders 2Health News:'Long-shot' discovery may lead to advances in treating anxiety, memory disorders 3Health News:Clinical waste management needs specialized regulation 2Health News:VIB-K.U. Leuven scientists clear the way to alternative anti-angiogenic cancer therapy 2
... it comes to medication administration, any error ... make. The solution is the Dynamic Hospital ... bar-coded medication administration system, suitable for hospitals ... used stand-alone, networked, or as a fully-integrated ...
... that support the nursing process. The caregiver ... I&O information at the point of collection ... This design supports compliance with documentation requirements., ... at the nursing station, wCareAssist™ is right ...
... that identifies the patient, tying all critical information to the patient's unique bar-coded identifier for accurate, easy recording ... ... ... ...
The Metrologic MS9520 Voyager is a high performance single line laser bar code scanner with automatic activation and sophisticated data transmission via Metrologic proprietary CodeGate technology....
Medicine Products: